ctrl K

Price Alert

Esperion Therapeutics Inc... (ESPR)

NASDAQ: ESPR · Real-Time Price · USD

2.15

0.08 (3.86%)

At close: Aug 15, 2025, 9:56 AM

Esperion Therapeutics Balance Sheet Statement

Financials in USD. Fiscal year is January - December.

Fiscal Year	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021
Cash & Equivalents	144.76M	82.25M	124.78M	208.89M
Short-Term Investments	n/a	n/a	42.09M	50.44M
Long-Term Investments	n/a	n/a	42.09M	50.44M
Other Long-Term Assets	n/a	n/a	-42.09M	50M
Receivables	80.14M	48.49M	33.73M	22.93M
Inventory	94.49M	65.62M	35.2M	34.39M
Other Current Assets	18.02M	4.51M	9.87M	n/a
Total Current Assets	338M	201.06M	246.68M	328.97M
Property-Plant & Equipment	5.77M	4.67M	1.2M	2.56M
Goodwill & Intangibles	56K	56K	56K	56K
Total Long-Term Assets	5.82M	4.73M	1.26M	52.62M
Total Assets	343.82M	205.8M	247.94M	381.59M
Account Payables	51.65M	31.72M	23.04M	17.56M
Deferred Revenue	8.52M	25.4M	3.51M	5.68M
Short-Term Debt	102.16M	34.83M	24.76M	11.29M
Other Current Liabilities	12.74M	49.24M	29.02M	24.7M
Total Current Liabilities	246.23M	156.22M	92.31M	73.35M
Long-Term Debt	483.74M	501.55M	259.9M	258.28M
Other Long-Term Liabilities	n/a	n/a	218.84M	245.74M
Total Long-Term Liabilities	486.31M	504.57M	479.41M	505.18M
Total Liabilities	732.54M	660.79M	571.72M	578.53M
Total Debt	591.21M	540.95M	260.95M	260.2M
Common Stock	196K	118K	75K	61K
Retained Earnings	-1.6B	-1.55B	-1.34B	-1.11B
Comprehensive Income	n/a	n/a	-2K	-31K
Shareholders Equity	-388.72M	-454.99M	-1.34B	-1.11B
Total Investments	n/a	n/a	84.17M	100.88M